Q2 2024 · 13F-HR
Alerce Investment Management, L.P.holdings as filed
Filed 2024-08-14 · accession 0000895345-24-000350
$51.0M
Reported value
5
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03589W102 | ANNX | ANNEXON INC | $36.3M | 71.1% | 7,406,024 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $5.9M | 11.5% | 5,747,906 | Common | SOLE |
| 03044L105 | — | AMERICAN WELL CORP | $3.4M | 6.67% | 10,475,717 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $3.1M | 6.04% | 213,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $2.4M | 4.67% | 1,630,830 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.